Sajan MP, Hansen BC, Higgs MG, Kahn CR, Braun U, Leitges M, Park CR, Diamond DM, Farese RV (2018) Atypical PKC, PKC/, activates -secretase and increases A1-40/42 and phospho-tau in mouse brain and isolated neuronal cells, and may link hyperinsulinemia and other aPKC activators to development of pathological and memory abnormalities in Alzheimer's disease
Additionally, this dose may fluctuate over time, which is why continued medical supervision and check-ins are recommended
However, most studies on cognition in people with CKD have been cross-sectional and associative, offering limited insight into causation
Meanwhile, in Wegovy clinical trials, 44% of those taking the drug experienced nausea while 24% had vomiting and 20% had abdominal pain, 11 all common symptoms of gastroparesis